Group 1 - Dachen Biotech (00809.HK) announced a debt restructuring arrangement with suppliers, establishing a partnership to facilitate this process [1] - The debt-to-equity swap agreement involves suppliers converting a total debt of RMB 461.1 million into equity, resulting in approximately 28.98% ownership in Century Dachen [1][2] - The completion of the debt-to-equity swap is contingent upon obtaining all necessary regulatory approvals, including those from the Ministry of Commerce [2] Group 2 - The debt-to-equity swap agreement includes a lock-up provision, preventing suppliers from selling or encumbering their shares except for the purpose of the debt restructuring [2] - A discount of no less than 30% is anticipated on the debt, with expected net gains of at least HKD 190 million from the debt restructuring [3] - Following the completion of the equity swap, Century Dachen will remain a wholly-owned subsidiary of the company, with no overall impact on the company's equity in Century Dachen [3]
大成生化科技(00809.HK)开始供应商债务重组安排